Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer

被引:0
作者
Ida Skarping
Daniel Förnvik
Sophia Zackrisson
Signe Borgquist
Lisa Rydén
机构
[1] Lund University,Division of Oncology and Pathology, Department of Clinical Sciences
[2] Skåne University Hospital,Department of Clinical Physiology and Nuclear Medicine
[3] Lund University,Medical Radiation Physics, Department of Translational Medicine, Skåne University Hospital
[4] Lund University,Diagnostic Radiology, Department of Translational Medicine, Department of Imaging and Functional Medicine, Skåne University Hospital
[5] Aarhus University Hospital,Department of Oncology
[6] Lund University,Division of Surgery, Department of Clinical Sciences
[7] Skåne University Hospital,Department of Surgery
[8] Aarhus University,undefined
来源
Breast Cancer Research and Treatment | 2021年 / 189卷
关键词
Breast cancer; Neoadjuvant chemotherapy; Imaging; Ultrasound; Axillary lymph nodes;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:131 / 144
页数:13
相关论文
共 418 条
[1]  
Burstein HJ(2019)Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019 Ann Oncol 30 1541-1557
[2]  
Curigliano G(2012)Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes J Clin Oncol 30 1796-1804
[3]  
Loibl S(2014)Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis Lancet 384 164-172
[4]  
Dubsky P(2013)Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study Lancet Oncol 14 609-618
[5]  
Gnant M(2013)Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial JAMA 310 1455-1461
[6]  
Poortmans P(2015)Evaluation of lymph node status after neoadjuvant chemotherapy in breast cancer patients: comparison of diagnostic performance of ultrasound, MRI and (1)(8)F-FDG PET/CT Br J Radiol 88 20150143-442
[7]  
Colleoni M(2019)Diagnostic accuracy of different surgical procedures for axillary staging after neoadjuvant systemic therapy in node-positive breast cancer: a systematic review and meta-analysis Ann Surg 269 432-3393
[8]  
Denkert C(2015)Axillary ultrasound after neoadjuvant chemotherapy and its impact on sentinel lymph node surgery: results from the American College of Surgeons Oncology Group Z1071 Trial (Alliance) J Clin Oncol 33 3386-S475
[9]  
Piccart-Gebhart M(2017)ACR appropriateness criteria((R)) monitoring response to neoadjuvant systemic therapy for breast cancer J Am Coll Radiol 14 S462-1612
[10]  
Regan M(2013)Axillary staging of breast cancer: what the radiologist should know Radiographics 33 1589-208